Crossroads Clinical Research, LLC

Victoria, Texas

We've found

1 trials

at this facility

Safety, Tolerability, and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Victoria, TX

Use our guide to learn which trials are right for you!